Mavyret and Nitroglycerin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavyret (glecaprevir; pibrentasvir) and Nitroglycerin (nitroglycerin). Common drug interactions include anaemia among females and oedema peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Mavyret and Nitroglycerin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Mavyret?

Mavyret has active ingredients of glecaprevir; pibrentasvir. eHealthMe is studying from 10,533 Mavyret users. Check the latest studies of Mavyret.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

On Jul, 14, 2026

16 people who take Mavyret and Nitroglycerin together, and have interactions are studied.

Mavyret and Nitroglycerin drug interactions.

What are the common drug interactions of Mavyret and Nitroglycerin, by gender? *:

female:

Anaemia (lack of blood)
Dizziness
Fatigue (feeling of tiredness)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Myalgia (muscle pain)
Pyrexia (fever)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Fluid overload (too much fluid in the blood)
Kidney transplant rejection

male:

Oedema peripheral (superficial swelling)
Dyspnoea (difficult or laboured respiration)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Headache (pain in head)
Immunodeficiency
Pneumonia
Atelectasis (partial or complete collapse of the lung)
Death
Depression
Fall

What are the common drug interactions of Mavyret and Nitroglycerin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fatigue (feeling of tiredness)

40-49:

n/a

50-59:

Anaemia (lack of blood)
Dizziness
Fatigue (feeling of tiredness)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Myalgia (muscle pain)
Oedema peripheral (superficial swelling)
Pyrexia (fever)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Cardiac failure congestive

60+:

White blood cell count decreased
Abdominal discomfort
Atelectasis (partial or complete collapse of the lung)
Depression
Fall
Gallbladder enlargement
Gallbladder oedema (swelling of gallbladder)
Haematemesis (vomiting of blood)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic mass

What are the existing conditions these people have? *

Hepatitis C: 10 people, 62.50%
High Blood Pressure: 4 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
Pain: 2 people, 12.50%
Depression: 2 people, 12.50%
Type 2 Diabetes: 1 person, 6.25%
Cardiac Failure: 1 person, 6.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
Colitis (inflammation of colon): 1 person, 6.25%
Constipation: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Mavyret and Nitroglycerin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously